openPR Logo
Press release

ASEAN and China Biosimilars Market Projected to Expand at a 29.7% CAGR By 2025

02-07-2020 01:51 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
ASEAN and China Biosimilars Market

ASEAN and China Biosimilars Market

The ASEAN and China biosimilars market was valued at $687.6 million in 2017 and is expected to reach $5,506.2 million by 2025 with a CAGR of 29.7% during the forecast period. Biosimilars are replicas of biologic drugs that are approved by the concerned regulatory authorities for use in the treatment of several medical indications.

Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/5080

According to the U.S. law, a biosimilar is approved based on its similarity to the FDA-approved biological product, also known as the reference product. Biosimilars have gained immense traction over the years as they are anticipated to offer immense savings to healthcare systems along with increased access to the advanced treatments. The principles behind development of biosimilars are same and regulations for biosimilars play a vital role in maintaining the viability and balance between original and biosimilar products. However, stringency of these regulations is expected to create hurdles in the growth of the biosimilar industry. In addition, rise in prevalence of chronic diseases such as cancer and diabetes, has fueled the demand for pharmaceutical drugs, especially the high-priced patented drugs.

In such cases, the cost of reference biologics exceeds the healthcare expenditure. This increased cost of drugs triggered the need for biosimilar products that provide similar efficacy and quality at low cost. The ASEAN and China biosimilars market is segmented based on molecule type, application, and region. Based on molecule type, monoclonal antibodies segment has dominated the market from 2017 to 2025. Whereas, the human growth hormone molecule segment registered the highest CAGR during 2018-2025 in the ASEAN and China biosimilars market. Upsurge in unmet needs for cancers has propelled global pharmaceutical giants to invest in the development of monoclonal antibody biosimilars and increase their accessibility across the ASEAN countries and China.

Key Findings of the ASEAN and China Biosimilars Market:
o Indonesia generated the highest revenue in the ASEAN biosimilars market in 2017 and is expected to remain dominant throughout the forecast period.
o Based on molecule type, the erythropoietin segment accounted for the second highest share in the ASEAN and China biosimilars market in 2017 and is expected to maintain this trend throughout the forecast period.
o Based on application, the blood disorders segment is estimated to rank second in terms of revenue in both, the ASEAN, and the China biosimilars market throughout the analysis period.
o The diabetes segment generated the highest CAGR from 2018 to 2025 in the ASEAN and China biosimilars market.

Access full Report: https://www.alliedmarketresearch.com/asean-and-china-biosimilars-market

Based on application, the oncology diseases segment generated the highest revenue in 2017 and is anticipated to maintain this trend throughout the forecast period. In addition, the chronic and autoimmune diseases segment is anticipated to grow at the fastest pace from 2018 to 2025 in the market. The demand for biosimilars in the treatment of oncological indications has witnessed considerable increase in recent years. This is attributed to the escalating cost of cancer care that imposes significant burden on the healthcare systems across the ASEAN countries and China.

The major companies profiled in the report include 3SBIO Inc., Qilu Pharmaceutical, Novartis International AG (Sandoz International GmBH), Pfizer Inc. (Hospira), STADA Arzneimittel, Beijing SL Pharmaceutical Co., Ltd., Fosun Pharmaceutical (Shanghai Fosun Pharmaceutical Co., Ltd.), Amgen Inc., AstraZeneca Plc, and Teva Pharmaceutical Industries Ltd.

Related Reports:
Asia Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market
https://www.alliedmarketresearch.com/asia-pacific-nuclear-medicine-radiopharmaceuticals-and-stable-isotopes-market

Asia Pacific Autoimmune Disorders Treatment Market
https://www.alliedmarketresearch.com/asia-pacific-autoimmune-disorders-treatment-market

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Life Science Market: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ASEAN and China Biosimilars Market Projected to Expand at a 29.7% CAGR By 2025 here

News-ID: 1923660 • Views: 494

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for ASEAN

The 5th ASEAN Energy Outlook: ASEAN is on Track to Reach Their Energy Intensity …
Manila, 28 September 2017 – During the press conference for the 35th ASEAN Ministers on Energy Meeting (AMEM) and Associated Meetings today, ASEAN Centre for Energy (ACE) announced the launch of the 5th ASEAN Energy Outlook (AEO5). The Philippine Secretary of Energy, Alfonso G. Cusi, stated, “The Outlook provides us with pathway to address our long-term goals of achieving energy security, accessibility and affordability within the framework of sustainable development,
ASEAN Hard Luxury Goods Market Intelligence with Competitive Landscape
Luxury goods comprises of products such as accessories, footwear, apparel, watches and others which are quite expensive and target those consumers who belongs to premium class. The market for luxury goods consist of three types of end consumers, which includes kids lying between the age of 0-12 years, teenagers belonging to the age group of 13 to 19 years and the rest lies in adult group. Luxury goods market can
ASEAN Automotive Aftermarket to Grow at 9.6% CAGR through 2026
In Future Market Insights’ market report titled, “Automotive Aftermarket: ASEAN Industry Analysis and Opportunity Assessment, 2016-2026”, poor road infrastructure and extended vehicle life have been identified as profitable factors for the growth of the automotive aftermarket in ASEAN. On account of growing out-of-warranty car parc, the US$ 19.3 Bn ASEAN automotive aftermarket is predicted to surpass US$ 48 Bn in revenues by 2026 end, increasing at a healthy CAGR of
Research Offers 10-Year Forecast on ASEAN Cosmetic Chemicals Market
The growing beauty products market has been increasing the demand for value-enriched cosmetics. The market is flooded with various cosmetic chemicals. Cosmetic chemicals are the basic ingredients found in cosmetic products including soap, shampoo, lipstick, mascara, deodorants and other beauty products (excluding the products listed under therapeutic goods). At present, various cosmetic business enterprises use more than 5000 different chemical compositions to offer selected cosmetic products. Based on its end
ASEAN Automotive Aftermarket to Grow at 9.6% CAGR through 2026
In Future Market Insights’ market report titled, “Automotive Aftermarket: ASEAN Industry Analysis and Opportunity Assessment, 2016-2026”, poor road infrastructure and extended vehicle life have been identified as profitable factors for the growth of the automotive aftermarket in ASEAN. On account of growing out-of-warranty car parc, the US$ 19.3 Bn ASEAN automotive aftermarket is predicted to surpass US$ 48 Bn in revenues by 2026 end, increasing at a healthy CAGR of
ASEAN Automotive Aftermarket In-depth market segmentation by 2025
Future Market Insights (FMI) announces release of its latest market report titled, “Automotive Aftermarket: ASEAN Industry Analysis and Opportunity Assessment 2015 - 2025”. According to this report, the ASEAN automotive aftermarket is anticipated to account for US$ 37.7 Bn by 2025, registering a compound annual growth rate (CAGR) of 7.8% throughout the forecast period. The report analyses and forecasts the ASEAN automotive aftermarket in terms of market value (US$ Bn)